Product Details

Phesgo 1200mg/600mg/15ml#

Pertuzumab; Trastuzumab
1200mg/15ml; 600mg/15ml
Injection

ROA

Subcutaneous

Applicant Name

Roche Products Limited

NRN

A6-100063

Status

Active


Composition

 

ATC Code

L01FY01  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 vial  

Product Description

Phesgo 1200mg/600mg/15ml Pertuzumab and Trastuzumab Active Substances . Pertuzumab 1200mg , trastuzumab 600mg Excipients Human hyaluronidase (rHuPH20) (produced by recombinant DNA technology using CHO [Chinese hamster ovary] cells) -, L-histidine hydrochloride monohydrate 53.7mg , L-histidine 6.75mg, a,a-trehalose dehydrate 397mg , sucrose 685mg , polysorbate 20* 6.00mg, L-methionine 22.4mg , water for injection QS to 15ml . Vaccines & Biologicals Biologics Imported Products 1 11/10/2021 Roche Products Limited, 8th Floor, Roche Office 21 Mobolaji Bank Anthony Way, Etiebet's Place, Ikeja. Lagos 8056292219 angela.essien@roche.com F.Hoffmann La Roche Limited, Wurmisweg 4303, Kaiseraugst, Switzerland, F.Hoffmann La Roche Limited, Wurmisweg 4303, Kaiseraugst, Switzerland, Switzerland

Manufacturer Name

F.Hoffmann La Roche Limited

Manufacturer Country

SWITZERLAND  

Approval Date

2022-11-02  

Expiry Date

2027-11-01